| abstract |
HBV replication inhibitors of formula (I) including stereochemically isomeric forms, as well as their salts, hydrates, solvates, where X, R-R have the meanings defined in the document. The invention also relates to methods for producing these compounds, to pharmaceutical compositions containing them, as well as to their use alone or in combination with other HBV inhibitors in the treatment of HBV. |